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Community-acquired pneumonia (CAP) forms part of a broad 
spectrum of acute lower respiratory tract illness (LRTI) in children. 
This terminology recognises that LRTI is a spectrum of illness 
ranging from airway to parenchymal disease, dependent on the 
pathogen/s and the host response.[1] As prevention and management 
strategies for childhood pneumonia have been strengthened, so 
reductions in pneumonia incidence, severity and shifts in aetiology 
have occurred. Besides the impact on under-5 mortality, pneumonia 
in early childhood may reduce lung function, setting a trajectory for 
long-term impairment of lung health including the development 
of asthma or chronic obstructive pulmonary disease (COPD) in 
adulthood.
In South Africa (SA), with socioeconomic improvements, 
reduction in perinatal HIV transmission, increasing numbers of 
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Background. Pneumonia remains a major cause of morbidity and mortality among South African (SA) children. Improved immunisation 
regimens, strengthening of HIV programmes, better socioeconomic conditions and new preventive strategies have influenced the epidemiology 
of pneumonia. Furthermore, sensitive diagnostic tests and better sampling methods in young children improve aetiological diagnosis.
Objectives. To summarise current information on childhood community-acquired pneumonia (CAP) epidemiology and aetiology in 
children as part of the revised South African Thoracic Society guidelines.
Methods. The Paediatric Assembly of the South African Thoracic Society and the National Institute for Communicable Diseases expert 
subgroup on epidemiology and aetiology revised the existing SA guidelines.The subgroup reviewed the published evidence in their area; in 
the absence of evidence, expert opinion was accepted. Evidence was graded using the British Thoracic Society (BTS) grading system, and 
the relevant section underwent peer review.
Results. Respiratory viruses, particularly respiratory syncytial virus, are the key pathogens associated with hospitalisation for radiologically 
confirmed pneumonia in HIV-uninfected children. Opportunistic organisms, including Pneumocystis jirovecii, are important pathogens in 
HIV-infected infants, while non-typable Haemophilus influenzae and Staphylococcus aureus are important in older HIV-infected children. 
Co-infections with bacteria or other respiratory viruses are common in hospitalised children. Mycobacterium tuberculosis is common in 
children hospitalised with CAP in SA.
Conclusions. Numerous public health measures, including changes in immunisation schedules and expansion of HIV prevention 
and treatment programmes, have influenced the epidemiology and aetiology of CAP in SA children. These changes have 
necessitated a revision of the South African Paediatric CAP guidelines, further sections of which will be published as part of a 
CME series in SAMJ.
S Afr Med J 2020;110(7):583-587. https://doi.org/10.7196/SAMJ.2020.v110i7.14997
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HIV-exposed uninfected (HEU) children, effective combination 
antiretroviral therapy (ART) programmes, and improved 
immunisation, the epidemiology and aetiology of childhood 
pneumonia is changing. In addition, improved diagnostic methods 
have highlighted the importance of multiple pathogens contri-
buting to co-infection in the aetiology of respiratory illness, and 
the importance of organism interactions. Current treatment and 
preventive strategies for childhood pneumonia therefore require 
revision.
Epidemiology
Pneumonia is one of the most common causes of morbidity and 
mortality in SA children, despite improvements in immunisation and 
HIV management programmes. In 2017, there were ~320 000 pneu -
monia episodes and 4 100 deaths in SA children aged <5 years.[2] 
The incidence of pneumonia in children <5 years old in SA has 
declined by ~50% from 2000 to 2015, including an estimated 71% 
reduction in children living with HIV (CLWH).[3] The roll-out of 
interventions to prevent mother-to-child transmission (PMTCT) of 
HIV and increased provision of ART to HIV-infected individuals 
has contributed to the decline in pneumonia cases.[4] Furthermore, 
following introduction of pneumococcal conjugate vaccine (PCV) into 
the SA public immunisation programme in 2009, PCV immunisation 
was estimated to have reduced under-5 hospitalisations for all-cause 
pneumonia by 33% and 39% in HIV-uninfected and HIV-infected 
children, respectively, by 2014.[5] Invasive pneumococcal disease 
has also declined by 69% among children <2 years, including 
an 89% reduction in PCV7 serotypes and a 57% reduction in 
PCV13 serotypes in 2012.[6] Despite these reductions, pneumonia 
remains one of the most important causes of death in SA children 
<5 years of age and is a major cause of healthcare utilisation and 
morbidity.[7,8] There are several determinants of pneumonia severity 
and mortality. The case fatality risk among children hospitalised with 
pneumonia in 5 SA hospitals was 2% from 2009 to 2012,[8,9] with HIV 
infection an important risk factor for hospitalisation and in-hospital 
mortality.[10] HEU infants have an increased risk of hospitalisation 
compared with HIV-unexposed infants and an increased risk of 
in-hospital death, predominantly in the first 6 months of life.[11,12] 
Increased risk of hospitalisation in HEU infants has also been 
found for specific pathogens such as pneumococcus, respiratory 
syncytial virus (RSV) and influenza virus.[10,11,13] Additional risk 
factors for severe pneumonia include infancy (particularly those 
<4 months), premature birth, incomplete immunisation, maternal 
smoking or household tobacco smoke exposure, indoor air pollution, 
low birthweight, malnutrition, lack of exclusive breastfeeding and 
overcrowding.[9,14,15]
Summary: Epidemiology
1.  Pneumonia incidence in children has declined by around 50% 
from 2000 to 2015, with an estimated 70% reduction in episodes in 
HIV-infected children.
2.  A reduction in vertical transmission of HIV, increased provision of 
ART, and PCV have contributed to this reduction.
3.  Pneumonia remains a major cause of morbidity and death in SA 
children.
4.  Risk factors for pneumonia hospitalisation include: HIV infection, 
HIV exposure (predominantly in infants), young age (particularly 
those <4 months), premature birth, incomplete immunisation, 
maternal smoking or household tobacco smoke exposure, indoor 
air pollution, low birthweight, malnutrition, non-exclusive 
breastfeeding and overcrowding.
Aetiology of pneumonia in children
A wide spectrum of pathogens, ranging from viral and bacterial 
to fungal and parasitic organisms, is implicated in pneumonia 
pathogenesis, and disease may be due to multiple organisms (evidence 
level Ia). If children are hospitalised with pneumonia, bacterial-viral 
co-infection is often the norm (evidence level Ib).[16,17] In the current 
era of conjugate vaccines targeting Haemophilus influenzae type b 
(Hib) and Streptococcus pneumoniae, there has been a shift in the 
spectrum of pathogens causing pneumonia, with viruses contributing 
to a greater proportion of severe LRTI episodes (evidence level Ib) 
and non-typable H. influenzae and S. aureus emerging as important 
bacterial pathogens.[18-24]
Bacterial organisms
The Drakenstein Child Health Study and the Pneumonia Etiology 
Research for Child Health (PERCH) case-control studies indicate that 
non-typable H. influenzae and S. aureus are now the leading bacterial 
causes of severe pneumonia in SA children (Supplementary Table 1; 
http://samj.org.za/public/sup/14997.docx) (evidence level Ib).[21,25,26]
Children presenting with empyema or pleural effusion, 
confluent dense consolidation or pneumatocoele on chest X-ray 
associated with high-grade pyrexia and elevation of acute-phase 
reactants (e.g. C-reactive protein), or those with features of 
suppurative lung disease, are highly likely to have a bacterial 
cause (evidence level Ib).[27,28] The most frequently isolated bacteria are 
S. aureus, non-typable H. influenzae, S. pneumoniae and S. pyogenes 
(group A Streptococcus).[27,29]
Gram-negative enteric organisms, particularly Klebsiella 
pneumoniae, Escherichia coli, Enterobacter cloacae and Salmonella 
spp. are important pneumonia pathogens in HIV-infected and 
malnourished children in sub-Saharan Africa (evidence level Ib).[30-32] In 
the Child Health and Mortality Prevention Surveillance (CHAMPS) 
programme, a study designed to establish the infectious aetiology 
of fatal illness in children dying in hospital, K. pneumoniae was 
identified in 16% of CAP deaths, and the most common organism 
isolated in death from hospital-acquired infection in Soweto.[33] 
Non-fermenting Gram-negatives, such as Moraxella catarrhalis or 
Pseudomonas aeruginosa, are increasingly recognised as contributors 
to bacterial pneumonia in children (evidence level II).
Bordetella pertussis is an important cause of pneumonia in young 
infants who are unimmunised or incompletely immunised. In Cape 
Town, B. pertussis prevalence among young children hospitalised 
with pneumonia was 16% in CLWH, 11% in HEU and 5% in 
HIV-unexposed children.[34] In the PERCH study, B. pertussis was 
detected in 2% of HIV-uninfected and 1% of HIV-infected children 
hospitalised with severe or very severe pneumonia.[25,26]
Tuberculosis
Mycobacterium tuberculosis is increasingly recognised as an important 
pathogen in acute pneumonia in settings with a high burden of 
tuberculosis and HIV (evidence level Ib). In SA, 43 - 85% of children 
with culture-confirmed tuberculosis presented with acute cough 
(<14 days) (evidence level Ib).[32,35-37] In the Drakenstein study, the 
incidence of tuberculin skin test (TST) conversion was 12 per 100 child 
years, and that of pulmonary tuberculosis 2.9 per 100 child years (evidence 
level Ib).[38] In the PERCH study, 3% of SA children hospitalised 
with World Health Organization-defined severe pneumonia had 
microbiologically confirmed tuberculosis (evidence level Ib).[39] Given 
the suboptimal sensitivity of mycobacterial culture, the proportion of 
SA paediatric pneumonia cases associated with M. tuberculosis is likely 
to be in the region of 7 - 15% (evidence level IVa).[25,26,38]
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If pulmonary tuberculosis is diagnosed, the child must be 
notified and treatment should be initiated in accordance with 
the South African Guidelines for the Management of Tuber-
culosis in Children (2013) (https://health-e.org.za/2014/06/10/
guidelines-management-tuberculosis-children/https://health-e.
org.za/wp-content/uploads/2014/06/National-Childhood-TB-
Guidelines-2013.pdf).
Respiratory viruses
Respiratory viruses are the leading cause of pneumonia and 
of hospitalisation in young children (evidence level Ia).[9,20,40] 
Respiratory virus-related illness follows predictable seasonal shifts; 
in SA this season is between March and September (autumn 
to early spring) (evidence level II).[41,42] RSV causes 18 - 31% of 
pneumonia episodes (evidence level Ia).[43] Other viruses associated 
with pneumonia include influenza, para-influenza, human 
metapneumovirus (HMPV), human rhinovirus and adenovirus 
(Supplementary Table 2; http://samj.org.za/public/sup/14997.docx) 
(evidence level Ib).[9,21,24]
Respiratory viruses are diverse, continually adapting and prone 
to causing intermittent epidemics and pandemics, particularly when 
adapting from animal reservoirs to the human host. Numerous 
pandemic influenza events occurred in the 20th century,[44] and 
the pandemic 2009 H1N1 influenza strain was implicated in the 
first influenza pandemic of the 21st century. Coronaviruses, too, 
have been associated with epidemics in recent decades.[45-48] Highly 
virulent influenza and coronavirus outbreaks may be associated with 
considerable case fatality risk, and it is for this reason that all cases of 
severe acute respiratory syndrome in which no alternative aetiological 
diagnosis is made be investigated for novel respiratory viruses. 
Such cases constitute a Category 1 Notifiable Medical Condition 
in SA (https://www.nicd.ac.za/wp-content/uploads/2017/06/NMC-
list_2018.pdf) and as such should be notified within 24 hours of 
diagnosis.
Although novel COVID-19 infection appears to affect children 
mildy, with most developing asymptomatic or mild illness,[49] 
children with acute lower respiratory illness requiring hospitalisation 
should be tested for SARS-CoV-2 through the epidemic. Evidence on 
COVID-19 in children is rapidly evolving and current management 
of paediatric cases should defer to recommendations from the 
National Department of Health (https://www.nicd.ac.za/diseases-
a-z-index/covid-19/covid-19-guidelines/). Children infected with 
SARS-CoV-2 may present with non-respiratory illness including 
multisystem inflammatory disease; and so, where resources permit, 
hospitalised children may be screened for infection, especially if there 
is a history of contact with a positive adult.
Viral-viral co-infections and viral-bacterial co-infections are 
increasingly recognised in the pathogenesis of severe pneumonia 
(evidence level Ib).[50] Preceding respiratory viral infection may 
prime the respiratory tract for new acquisition of bacterial 
colonisation, and increase in density of colonisation, or vice versa 
(evidence level Ib).[51-53]
Measles and varicella-zoster virus occasionally cause severe, or 
fatal, pneumonia in the context of outbreaks or epidemics (evidence 
level II). Typically, malnourished or immunocompromised children 
tend to develop the most severe forms of pneumonia related to these 
organisms.[54,55] Children hospitalised with measles or varicella-
zoster virus-associated pneumonia frequently develop superimposed 
bacterial pneumonia (primarily S. aureus and S. pyogenes) and 
require treatment with broad-spectrum antibiotic therapy (evidence 
level IVa).[56-58]
Opportunistic organisms
Pneumocystis jirovecii, either alone or as a co-pathogen with 
cytomegalovirus (CMV), is a leading infection in CLWH not on ART 
in SA (evidence level Ib).[26,59-62] Typically, pneumocystis pneumonia 
(PCP) affects young infants, between 6 weeks and 6 months of age; 
presentation is with severe hypoxia, dyspnoea, low-grade fever and 
normal chest auscultation (evidence level Ib).[63] However, P. jirovecii 
also commonly colonises the airways in infants.
The association of CMV alone with severe childhood pneu monia in 
HIV-infected and HEU children is contentious (evidence level II),[64,65] 
although histological evidence of CMV pneumonia is frequently seen 
in HIV-infected children dying of pneumonia.[66] Fatal disseminated 
disease associated with CMV is also well described in children who 
are solid organ or bone marrow transplant recipients.[67,68]
Atypical bacteria
Chlamydophila pneumoniae, Chlamydia trachomatis, Mycoplasma 
pneumoniae and Legionella spp. are infrequently associated with 
pneumonia in SA children (evidence level II),[21,25,26,69] but should be 
considered in the differential diagnosis in children with progressive 
respiratory failure, despite broad-spectrum antibiotic cover (evidence 
level IVa). Age <5 years of age and HIV infection were associated with 
hospitalisation for severe M. pneumoniae in SA.[70]
Summary: Aetiology
Co-infections are common in pneumonia pathogenesis.
1.  The most frequently isolated bacterial pathogens following 
PCV and Hib immunisation are non-typable H. influenzae and 
S. aureus.
2.  B. pertussis is implicated in severe pneumonia aetiology in those 
with incomplete immunisation.
3.  M. tuberculosis is an important pathogen in settings with a high 
burden of tuberculosis.
4.  Gram-negative bacteria are important pathogens in HIV-infected 
and malnourished children.
5.  Respiratory viruses, particularly RSV, are responsible for most 
pneumonia episodes. Influenza, para-influenza, adenovirus and 
human bocavirus, HMPV and rhinovirus are common, although 
not always pathogenic.
6.  In HIV-infected children not on ART, P. jirovecii either alone 
or as a co-pathogen with CMV, is an important opportunistic 
infection.
Special circumstances: HIV infection 
or exposure
HIV infection rates in children have declined significantly with 
the advent of effective PMTCT interventions, from 30% to 1 - 3% 
in SA.[71] There is subsequently a large population of children born 
to HIV-infected mothers who are HEU.[71] HEU infants have an 
increased risk of pneumonia, particularly in the first 6 months of 
life (evidence level Ib).[10] The exact mechanisms of vulnerability in 
HEU infants may involve in utero exposure to HIV viral proteins, 
exposure to ART, lack of effective protective maternal antibodies, or 
abnormalities in immunological responses (evidence level III).[71,72]
Prior to the ART roll-out, CLWH had a 4 - 6-fold increased risk 
of developing severe pneumonia,[14,73] and a 4 - 6-fold increased 
risk of death once hospitalised for pneumonia (evidence level II).[9,73] 
However, widespread use of ART has markedly reduced this burden, 
with a decline in mortality rates among children on ART from 7.1 per 
100 person-years to 0.6 per 100 person-years in a multicentre 
prospective cohort study from the USA.[74]
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HIV-infected infants not on ART, especially those with viral 
load ≥100 000 copies/mL and CD4 <15%, are at greatest risk of 
developing severe disease (evidence level Ib).[75] Additional risk 
factors for severe disease include poor nutritional status and 
anaemia (evidence level Ib).[73]
Aetiology of pneumonia in HIV-infected children
In the era of ART, the aetiology of pneumonia is similar among 
CLWH, HEU and HIV-unexposed children (Supplementary Tables 1 
and 2; http://samj.org.za/public/sup/14997.docx).[76] However, in HIV-
infected infants, P. jirovecii is still the leading cause of hospitalisation.[26]
M. tuberculosis should be considered in HIV-infected children with 
pneumonia, as evidence suggests an increased risk for tuberculosis 
(evidence level Ib).[73] HIV-infected infants not on ART have a 20-fold 
higher risk of developing culture-confirmed tuberculosis compared 
with HIV-uninfected infants (evidence level 1b).[77] This risk declines 
with the introduction of ART.[78]
Summary: HIV infection or exposure
1.  A broader range of pathogens is responsible for pneumonia in 
CLWH, encompassing opportunistic infections such as PCP and 
CMV, S. aureus and Gram-negative organisms (evidence level Ib).
2.  M. tuberculosis should be considered in CLWH and HEU children, 
as there is an increased risk for tuberculosis in these populations 
(evidence level Ib).
Conclusions
Updated evidence on the epidemiology and aetiology of paediatric 
CAP in SA children is presented in this CME article. Epidemiological 
shifts in pneumonia burden have occurred, primarily through 
improvements in coverage for Hib and pneumococcus in the SA 
Extended Programme on Immunisation, as well as expansion of the 
ART roll-out and PMTCT programmes. Success in preventing HIV 
infection in SA infants has resulted in a growing population of HEU 
infants who themselves are at increased risk for CAP hospitalisation, 
however. Case-control studies of hospitalised childhood pneumonia 
conducted in SA during the past decade have highlighted the role of 
respiratory viruses in the aetiology of hospitalised pneumonia in young 
children; however, bacterial-viral or viral-viral co-infections may be 
more common in children with severe disease. M. tuberculosis is an 
important pathogen to consider in our high-burden setting. Although 
great progress has been made in widening access to ART for CLWH 
and in HIV prevention programmes, PCP is still the most important 
condition precipitating hospitalisation in HIV-infected infants.
Updated guidance on diagnosis, treatment and prevention of 
childhood pneumonia, based on current knowledge of pneumonia 
aetiology, are presented in parts 2,[79] 3[80] and 4[81] of the SA paediatric 
pneumonia guidance CME articles.
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